Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Discover why Novo Nordisk's current sell-off offers a strong buy opportunity. Backed by solid fundamentals, growth prospects, ...

Investing in attractive dividend growth stocks can lead to superior long-term returns. The two healthcare companies below ...

In the next 10 years, expect the company to do the same while benefiting from greater insurance coverage for CGM -- ...

Wall Street notched another record close on Thursday, as market participants snapped up equities and dumped bonds after nonfarm payrolls jumped more than expected in June. The S&P 500 Health Care ...

As you get closer and closer to retirement, making sound financial decisions can be a real headache as you decide how to put ...